A study of the epitopes on steroid 21-hydroxylase recognized by autoantibodies in patients with or without Addison's disease

Clinical and Experimental Immunology

Volumn 111, Issue 2, 1998, Pages 422-428

  Volpato, M ^c,d   Prentice, L ^a   Chen, S ^a,b   Betterle, C ^c   Rees Smith, B ^a,b   Furmaniak, J ^a,b  

^a RSR LTD   (United Kingdom)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY OF PADOVA   (Italy)

^d UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

21 hydroxylase; 21 hydroxylase epitopes; Addison's disease; Autoantibodies; Polyglandular autoimmune syndromes

Indexed keywords

AUTOANTIBODY; EPITOPE; STEROID 21 MONOOXYGENASE;

ADDISON DISEASE; ADOLESCENT; ADRENAL HYPERPLASIA; ADULT; ANTIGEN RECOGNITION; ARTICLE; AUTOIMMUNITY; CARBOXY TERMINAL SEQUENCE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MULTIPLE ENDOCRINE ADENOMATOSIS; PRIORITY JOURNAL;

EID: 0031911733     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1998.00475.x     Document Type: Article

References (25)

1. Bottazzo GF, Mirakian R, Drexhage HA. Adrenalitis, oophoritis and autoimmune polyglandular disease. In: Rich RR, Fleisher TA, Schwartz DB, Shearer WT, Strober W, eds. Clinical immunology. Principles and practice. St Louis: Mosby, 1996: 1523-36.
2. Neufeld M, Blizzard RM. Polyglandular autoimmune disease. In: Pinchera A, Doniach D, Fenzi GK, Baschieri L, eds. Symposium on autoimmune aspects of endocrine disorders. New York: Academic Press, 1980: 357-65.
3. Bednarek J, Furmaniak J, Wedlock N et al. Steroid 21-hydroxylase is a major autoantigen involved in adult onset autoimmune Addison's disease. FEBS 1992; 309:51-55.
4. Winqvist O, Karlsson FA, Kampe O. 21-Hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992; 339:1559-62.
5. Song Y-H, Connor EL, Muir A et al. Autoantihody epitope mapping of the 21-hydroxylase antigen in autoimmune Addison's disease. J Clin Endocrinol Metab 1994; 78:1108-12.
6. Uibo R, Aavik E, Peterson P et al. Autoantibodies to cytochrome P450 enzymes P450scc, P450c17, and P450c21 in autoimmune polyglandular disease types I and II and in isolated Addison's disease. J Clin Endocrinol Metab 1994; 78:323-8.
7. Colls J, Betterle C, Volpato M et al. A new immunoprecipitation assay for autoantibodies to steroid 21-hydroxylase in Addison's disease. Clin Chem 1996; 41:375-80.
8. Falorni A, Nikoshkov A, Laureti S et al. High diagnostic accuracy for idiopathic Addison's disease with a sensitive radiobinding assay for autoantibodies against recombinant human 21-hydroxylase. J Clin Endocrinol Metab 1995; 80:2752-5.
9. Chen S, Sawicka J, Betterle C et al. Autoantibodies to steroidogenic enzymes in autoimmune polyglandular syndrome, Addison's disease, and premature ovarian failure. J Clin Endocrinol Metab 1996; 81:1871-6.
10. Betterle C, Volpato M, Rees Smith B et al. I. Adrenal cortex and steroid 21-hydroxylase autoantibodies in adult patients with organ-specific autoimmune diseases: markers of low progression to clinical Addison's disease. J Clin Endocrinol Metab 1997; 82:932-8.
11. Betterle C, Volpato M, Rees Smith B et al. II. Adrenal cortex and steroid 21-hydroxylase autoantibodies in children with organ-specific autoimmune diseases: markers of high progression to clinical Addison's disease. J Clin Endocrinol Metab 1997; 82: 939-2.
12. Wedlock N, Asawa T, Baumann-Antczak A et al. Autoimmune Addison's disease. Analysis of autoantibody binding sites on human steroid 21-hydroxylase. FEBS 1993; 332:123-6.
13. Asawa T, Wedlock N, Baumann-Antczak A et al. Natural occurring mutations in human steroid 21-hydroxylase influence adrenal autoantibody binding. J Clin Endocrinol Metab 1994; 79:372-6.
14. Betterle C, Scalici C, Presotto F et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988; 117:467-5.
15. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1979; 227:680-4.
16. Smith DB, Corcoran LM. Expression and purification of glutathione-S-transferase fusion proteins. Current Protocols Mol Biol 1994; 2:1671-7.
17. Struhl K. Synthesizing proteins in vitro by transcription and translation of cloned genes. Current Protocols Mol Biol 1994; 2:10170-5.
18. Jaume JC, Costante G, Nishikawa T et al. Thyroid peroxidase autoantibody fingerprints in hypothyroid and euthyroid individuals. 1. Cross-sectional study in elderly women. J Clin Endocrinol Metab 1995; 90:994-9.
19. Saabori AM, Caturegli P, Rose NR et al. Tryptic peptides of human thyroglobulin: II. Immunoreactivity with sera from patients with thryoid diseases. Clin Exp Immunol 1995; 98:459-66.
20. Prentice L, Kiso Y, Fukuma N et al. Monoclonal thyroglobulin autoantibodies: variable region analysis and epitope recognition. J Clin Endocrinol Metab 1995; 80:977-86.
21. Björk E, Velloso LA, Kämpe O et al. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes. Diabetes 1994; 43:161-5.
22. Daw K, Ujihara N, Atkinson M et al. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition. J Immunol 1996; 156:818-25.
23. Falorni A, Ackefors M, Calberg C et al. Diagnostic sensitivity of immunodominant epitopes of glutamic acid decarboxylase (GAD65) autoantibodies in childhood IDDM. Diabetologia 1996; 39:1091-8.
24. 35S-labelled intact and modified TPO. J Endocrinol 1996; 148 (Suppl.): OC31.
25. Czarnocka B, Pastuszko D, Carayon P et al. Majority of thyroid peroxidase autoantibodies in patients with thyroid disease are directed to a single TPO domain. Autoimmunity 1996; 23:145-54.